Table of Contents Author Guidelines Submit a Manuscript
Stem Cells International
Volume 2016, Article ID 2868323, 10 pages
http://dx.doi.org/10.1155/2016/2868323
Research Article

Role of Nitric Oxide, Nitric Oxide Synthase, Soluble Guanylyl Cyclase, and cGMP-Dependent Protein Kinase I in Mouse Stem Cell Cardiac Development

1Department of Neurofarba, Pharmacology and Toxicology Unit, University of Florence, Florence, Italy
2Interuniversity Center for Molecular Medicine and Applied Biophysics, Florence, Italy

Received 9 August 2016; Accepted 26 September 2016

Academic Editor: Michael Lichtenauer

Copyright © 2016 Valentina Spinelli et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Moncada, R. M. J. Palmer, and E. A. Higgs, “Nitric oxide: physiology, pathophysiology, and pharmacology,” Pharmacological Reviews, vol. 43, no. 2, pp. 109–142, 1991. View at Google Scholar · View at Scopus
  2. M. A. Marletta, “Nitric oxide synthase structure and mechanism,” The Journal of Biological Chemistry, vol. 268, no. 17, pp. 12231–12234, 1993. View at Google Scholar
  3. J. O. Lundberg, M. T. Gladwin, and E. Weitzberg, “Strategies to increase nitric oxide signalling in cardiovascular disease,” Nature Reviews Drug Discovery, vol. 14, no. 9, pp. 623–641, 2015. View at Publisher · View at Google Scholar · View at Scopus
  4. R. M. J. Palmer, A. G. Ferrige, and S. Moncada, “Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor,” Nature, vol. 327, no. 6122, pp. 524–526, 1987. View at Publisher · View at Google Scholar · View at Scopus
  5. B. Mayer and B. Hemmens, “Biosynthesis and action of nitric oxide in mammalian cells,” Trends in Biochemical Sciences, vol. 22, no. 12, pp. 477–481, 1997. View at Publisher · View at Google Scholar · View at Scopus
  6. M. T. Ziolo, M. J. Kohr, and H. Wang, “Nitric oxide signaling and the regulation of myocardial function,” Journal of Molecular and Cellular Cardiology, vol. 45, no. 5, pp. 625–632, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. E. J. Tsai and D. A. Kass, “Cyclic GMP signaling in cardiovascular pathophysiology and therapeutics,” Pharmacology and Therapeutics, vol. 122, no. 3, pp. 216–238, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. G. W. Booz, “Putting the brakes on cardiac hypertrophy: exploiting the NO-cGMP counter-regulatory system,” Hypertension, vol. 45, no. 3, pp. 341–346, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. S. H. Francis, J. L. Busch, and J. D. Corbin, “cGMP-dependent protein kinases and cGMP phosphodiesterases in nitric oxide and cGMP action,” Pharmacological Reviews, vol. 62, no. 3, pp. 525–563, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. L. Raeymaekers, F. Hofmann, and R. Casteels, “Cyclic GMP-dependent protein kinase phosphorylates phospholamban in isolated sarcoplasmic reticulum from cardiac and smooth muscle,” Biochemical Journal, vol. 252, no. 1, pp. 269–273, 1988. View at Publisher · View at Google Scholar · View at Scopus
  11. B. Sabine, R. Willenbrock, H. Haase et al., “Cyclic GMP-mediated phospholamban phosphorylation in intact cardiomyocytes,” Biochemical and Biophysical Research Communications, vol. 214, no. 1, pp. 75–80, 1995. View at Publisher · View at Google Scholar · View at Scopus
  12. M. Schmelter, B. Ateghang, S. Helmig, M. Wartenberg, and H. Sauer, “Embryonic stem cells utilize reactive oxygen species as transducers of mechanical strain-induced cardiovascular differentiation,” The FASEB Journal, vol. 20, no. 8, pp. 1182–1184, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. M. Noble, C. Pröschel, and M. Mayer-Pröschel, “Oxidative-reductionist approaches to stem and progenitor cell function,” Cell Stem Cell, vol. 8, no. 1, pp. 1–2, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Ushio-Fukai and N. Urao, “Novel role of NADPH oxidase in angiogenesis and stem/progenitor cell function,” Antioxidants & Redox Signaling, vol. 11, no. 10, pp. 2517–2533, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. F. Luna Crespo, V. R. Sobrado, L. Gomez, A. M. Cervera, and K. J. McCreath, “Mitochondrial reactive oxygen species mediate cardiomyocyte formation from embryonic stem cells in high glucose,” STEM CELLS, vol. 28, no. 7, pp. 1132–1142, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. F. Cecchi, I. Olivotto, S. Betocchi et al., “The Italian registry for hypertrophic cardiomyopathy: A Nationwide Survey,” American Heart Journal, vol. 150, no. 5, pp. 947–954, 2005. View at Publisher · View at Google Scholar · View at Scopus
  17. D. S. Burley, P. Ferdinandy, and G. F. Baxter, “Cyclic GMP and protein kinase-G in myocardial ischaemia-reperfusion: opportunities and obstacles for survival signaling,” British Journal of Pharmacology, vol. 152, no. 6, pp. 855–869, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. J. S. Krumenacker, S. Katsuki, A. Kots, and F. Murad, “Differential expression of genes involved in cGMP-dependent nitric oxide signaling in murine embryonic stem (ES) cells and ES cell-derived cardiomyocytes,” Nitric Oxide-Biology and Chemistry, vol. 14, no. 1, pp. 1–11, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. K. Mujoo, V. G. Sharin, N. S. Bryan et al., “Role of nitric oxide signaling components in differentiation of embryonic stem cells into myocardial cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 48, pp. 18924–18929, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. A. J. Hodge, J. Zhong, and E. A. Lipke, “Enhanced stem cell-derived cardiomyocyte differentiation in suspension culture by delivery of nitric oxide using S-nitrosocysteine,” Biotechnology and Bioengineering, vol. 113, no. 4, pp. 882–894, 2016. View at Publisher · View at Google Scholar
  21. V. Spinelli, L. Diolaiuti, A. Laurino et al., “Can NOS/sGC/cGK1 pathway trigger the differentiation and maturation of mouse embryonic stem cells (ESCs)?” in Proceedings of the Cardiovasc. Res, Abstract Book of: Frontiers in CardioVascular Biology 2016 Florence 8th—10th July Bienniel Congress of the ESC Council on Basic Cardiovascular Science, vol. 111, no. S1, p. S517, 2016.
  22. J. Nichols, E. P. Evans, and A. G. Smith, “Establishment of germ-line-competent embryonic stem (ES) cells using differentiation inhibiting activity,” Development, vol. 110, no. 4, pp. 1341–1348, 1990. View at Google Scholar · View at Scopus
  23. L. Sartiani, E. Bettiol, F. Stillitano, A. Mugelli, E. Cerbai, and M. E. Jaconi, “Developmental changes in cardiomyocytes differentiated from human embryonic stem cells: a molecular and electrophysiological approach,” Stem Cells, vol. 25, no. 5, pp. 1136–1144, 2007. View at Publisher · View at Google Scholar · View at Scopus
  24. C. Bartsch, M. M. Bekhite, A. Wolheim et al., “NADPH oxidase and eNOS control cardiomyogenesis in mouse embryonic stem cells on ascorbic acid treatment,” Free Radical Biology and Medicine, vol. 51, no. 2, pp. 432–443, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. X. Ma, N. Sayed, A. Beuve, and F. Van Den Akker, “NO and CO differentially activate soluble guanylyl cyclase via a heme pivot-bend mechanism,” The EMBO Journal, vol. 26, no. 2, pp. 578–588, 2007. View at Publisher · View at Google Scholar · View at Scopus
  26. C. Cai, L. Teng, D. Vu et al., “The heme oxygenase 1 inducer (CoPP) protects human cardiac stem cells against apoptosis through activation of the extracellular signal-regulated kinase (ERK)/NRF2 signaling pathway and cytokine release,” Journal of Biological Chemistry, vol. 287, no. 40, pp. 33720–33732, 2012. View at Publisher · View at Google Scholar · View at Scopus
  27. J. L. Busch, E. P. Bessay, S. H. Francis, and J. D. Corbin, “A conserved serine juxtaposed to the pseudosubstrate site of type I cGMP-dependent protein kinase contributes strongly to autoinhibition and lower cGMP affinity,” Journal of Biological Chemistry, vol. 277, no. 37, pp. 34048–34054, 2002. View at Publisher · View at Google Scholar · View at Scopus
  28. H. K. Haider, Y.-J. Lee, S. Jiang, R. P. H. Ahmed, M. Ryon, and M. Ashraf, “Phosphodiesterase inhibition with tadalafil provides longer and sustained protection of stem cells,” American Journal of Physiology—Heart and Circulatory Physiology, vol. 299, no. 5, pp. H1395–H1404, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. J.-D. Fu, J. Li, D. Tweedie et al., “Crucial role of the sarcoplasmic reticulum in the developmental regulation of Ca2+ transients and contraction in cardiomyocytes derived from embryonic stem cells,” The FASEB Journal, vol. 20, no. 1, pp. 181–183, 2006. View at Publisher · View at Google Scholar · View at Scopus
  30. N. Kapur and K. Banach, “Inositol-1,4,5-trisphosphate-mediated spontaneous activity in mouse embryonic stem cell-derived cardiomyocytes,” The Journal of Physiology, vol. 581, no. 3, pp. 1113–1127, 2007. View at Publisher · View at Google Scholar · View at Scopus
  31. T. Nashida, K. Takuma, S. Fukuda et al., “The specific Na+/Ca2+ exchange inhibitor SEA0400 prevents nitric oxide-induced cytotoxicity in SH-SY5Y cells,” Neurochemistry International, vol. 59, no. 1, pp. 51–58, 2011. View at Publisher · View at Google Scholar · View at Scopus